Clinical trial Recruiting at 1 site Observational

Genetic causes of neonatal encephalopathy and related conditions

Official title: Genetics of Neonatal Encephalopathy and Related Disorders

Run by Boston Children's Hospital · NCT07165938 · Data updated 2026-11-12

This project will see if DNA changes help explain neonatal encephalopathy in children under 6 who receive care at Boston Children's Hospital.

More Neonatal Encephalopathy trials

Quick facts

Study typeObservational
SexAll
Enrollment300 (estimated)
SponsorBoston Children's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedFebruary 4, 2026
Main results expectedSeptember 2035
Study endsSeptember 2035
Registry record updatedMarch 11, 2026
Trial IDNCT07165938 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children diagnosed with neonatal encephalopathy during the neonatal period who are under 6 years old at enrollment and are patients at Boston Children's Hospital, with biological parents eligible to provide samples.

Probably not a fit

Patients who already have a known genetic cause for their neonatal encephalopathy, who died before enrollment, or who are not patients at Boston Children's Hospital are not likely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational effort enrolls children diagnosed with neonatal encephalopathy during the newborn period (and, when available, their biological parents) who are patients at Boston Children's Hospital. Investigators collect clinical information from the medical record and biological samples for genetic testing to look for DNA variants that may cause or contribute to the condition. Genetic findings are then compared with each child's clinical features and outcomes to identify patterns and potential genetic causes. The work is noninterventional and focuses on improving diagnostic understanding rather than testing a treatment.

Why it matters

Potential benefit: If successful, this work could lead to more accurate diagnoses, better genetic counseling for families, and improved management plans for affected children.

How similar studies have gone: Previous genetic sequencing efforts have identified pathogenic variants in some infants with neonatal encephalopathy, but applying genetics broadly to NE is still emerging and not yet definitive for all cases.

Who can join: the full rules

Show full inclusion / exclusion criteria
Proband Criteria:

Inclusion Criteria:

* Diagnosed with neonatal encephalopathy during the neonatal period as documented in the electronic medical record
* Less than 6 years old at the time of study enrollment
* Patient at Boston Children's Hospital

Exclusion Criteria:

* Genetic cause of NE already identified
* Deceased prior to enrollment

Parent criteria:

Inclusion Criteria:

\- Biological parent of eligible proband (see above)

Where it's running

  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Using breast milk to treat brain injury in newborns

    This study is testing if giving breast milk through the nose can help newborns with brain injuries feel better and develop normally while they are being treated with cooling therapy.

    Recruiting Early Phase 1 Semmelweis University · Budapest · NCT06747260

  • Newborn Brain Wave Checker: See if CergenX Wave matches the Sarnat exam

    This study tests whether the CergenX Wave software, which analyzes a newborn's EEG via a small four-electrode setup, can match the standard Sarnat examination in babies with suspected neonatal encephalopathy.

    Recruiting CergenX Limited · Dallas, Texas and 1 other locations · NCT07857070

  • Neonatal Neurological Observation With Video AI

    This study tests a real-time, non-contact video AI system to help monitor brain health in newborns with suspected brain injury during their hospital stay.

    Recruiting Artemis AI Labs · New York, New York and 1 other locations · NCT07628829

  • Using intranasal breast milk to improve outcomes in newborns with brain injury

    This study is testing if giving fresh breast milk through the nose can help newborns with brain injury do better in the long run compared to standard care.

    Recruiting Early Phase 1 Semmelweis University · Budapest · NCT06746532

  • Virtual intervention for at-risk children with neurological issues

    This study is testing if a virtual program can help young children with neurological issues, like those born prematurely, just as well as in-person help does.

    Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT06643598

  • Using sildenafil to treat brain injury in newborns after asphyxia

    This study is testing if sildenafil can help newborns with brain injuries from lack of oxygen at birth recover better after treatment with cooling therapy.

    Recruiting at 3 sites Phase 2 McGill University Health Centre/Research Institute of the McGill University Health Centre · Denver, Colorado and 2 other locations · NCT06098833

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.